Understanding how patient-derived cancer organoids respond to treatment in cholangiocarcinoma
Defining Therapeutic Sensitivity of Patient-Derived Cancer Organoids in Cholangiocarcinoma
This study is looking at ways to create mini versions of your cancer to see how different treatments work, with the hope of finding better options for people with bile duct cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wm S. Middleton Memorial Veterans Hosp NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-11063125 on NIH RePORTER |
What this research studies
This research focuses on developing and standardizing patient-derived organoid models for cholangiocarcinoma, a type of bile duct cancer. By studying these organoids, researchers aim to better understand how different treatments affect cancer cells, which could lead to more effective therapies. The approach involves using organoids that mimic the patient's cancer to test various drugs and identify the most effective treatment options. This personalized approach aims to improve outcomes for patients suffering from this aggressive cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with cholangiocarcinoma who are seeking innovative treatment options.
Not a fit: Patients with early-stage cholangiocarcinoma or those not seeking treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment options for patients with cholangiocarcinoma.
How similar studies have performed: Previous research has shown success in using patient-derived organoids for other types of cancers, indicating potential for similar advancements in cholangiocarcinoma.
Where this research is happening
Madison, United States
- Wm S. Middleton Memorial Veterans Hosp — Madison, United States (Active)
Researchers
- Principal investigator: Kratz, Jeremy David — Wm S. Middleton Memorial Veterans Hosp
- Study coordinator: Kratz, Jeremy David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.